SecBot SecBot
Institutional Cluster

CGEM

Cullinan Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago
Institutional cluster: 3 buyers, 2 sellers (mixed)
Actionable Insight • Neutral

The cluster is too small and passive-dominated to drive a directional trade. Monitor for a higher-conviction catalyst (e.g., pipeline data, partnership) before acting. The 95% analyst bullish consensus is already priced in.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
CGEM ▲ +67.10% at T+60d
NEUTRAL call +67.10% · α vs SPY +63.28% · entry $12.98 → $21.69
Entry = T+0 close
Jun 11, 2026
via day close
T+1d
+5.55%
call +5.55% · α +5.01%
$13.70
settled 5mo ago
T+5d
+11.25%
call +11.25% · α +10.81%
$14.44
settled 4mo ago
T+20d
+41.60%
call +41.60% · α +39.71%
$18.38
settled 4mo ago
T+60d
+67.10%
call +67.10% · α +63.28%
$21.69
settled 7w ago

Executive Summary

Three institutional investors (Morgan Stanley, Invesco, RenTech) added to their CGEM positions in Q3 2025, while two (Fidelity, UBS) trimmed. The net buying of $1.3M is modest relative to the $741M market cap, and the cluster is dominated by passive/quant funds, limiting the signal's conviction.

Key Financial Metrics

Direction
mixed
Buy Value
$6.1M
Sell Value
$2.3M
Net Flow
$1.3M

Institutional Positions

Net institutional flow: $1.3M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Morgan StanleyADD+65.3%$2.4M$550.0K
InvescoADD+69%$607.0K$151.0K
RenTechADD+58.3%$3.1M$620.0K

▼ Sellers (2)

InstitutionActionChangePrev ValueValue Δ
FidelityTRIM-74.6%$29.0K-$23.0K
UBSTRIM-39.6%$2.3M-$1.2M

Key Facts

  • 3 buyers added $1.3M in net new holdings; 2 sellers reduced by $1.25M
  • Largest buyer: RenTech added $620K (+58.3% shares), now holds $3.1M
  • Largest seller: UBS trimmed $1.2M (-39.6% shares), now holds $1.1M
  • All participants are passive/quant funds — no activist or high-conviction active managers
  • 13F data is as of 2025-09-30; positions may have been unwound since

Financial Impact

Net institutional buying of ~$1.3M against a $741M market cap (~0.2% of float)

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale; positions may have reversed
  • No active manager participation reduces signal reliability

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CGEM-2025-Q3
16 reports for CGEM
Performance horizon
100% Hit rate @ T+60 6 of 6 directional calls Went positive at some point 9 of 11 best @ T+60▲ +68.15%Jun 8, 2026
Filters
Rows
Reports for CGEM — sortable, filterable
TypeNow
Oct 1, 2026
24d ago
Press Release
BULLISH ★ 7/10
$15.51awaiting T+60——
Sep 24, 2026
4w ago
8-K
NEUTRAL ★ 5/10
$15.44awaiting T+60——
Sep 24, 2026
4w ago
Press Release
BULLISH ★ 6/10
$15.44awaiting T+60——
Sep 22, 2026
4w ago
Institutional Cluster
BULLISH ★ 4/10
$21.67awaiting T+60——
Sep 14, 2026
6w ago
8-K
BULLISH ★ 7/10
$20.40awaiting T+60——
Aug 6, 2026
11w ago
8-K
BULLISH ★ 7/10
$17.95awaiting T+60——
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$12.98 $21.69▲ +67.10%▲ +63.28%—
Jun 10, 2026
19w ago
Press Release
NEUTRAL ★ 4/10
$12.05 $22.09▲ +83.32%▲ +77.15%—
Jun 8, 2026
20w ago
8-K
BULLISH ★ 6/10
$13.28 $22.33▲ +68.15%▲ +64.64%—
May 19, 2026
22w ago
Press Release
BULLISH ★ 5/10
$14.18 $19.64▲ +38.55%▲ +32.26%—
Showing 10 of 16

US Market Status

Market Closed — Opens Tue (15h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026